
Blue Moon Zinc Corp's stock surged by over 5% in the last trading session, driven by promising assay results from its Apex project.
In a notable market performance, Blue Moon Zinc Corp (MOON.V) saw its stock price climb by 5.05% to close at CA$8.74. This rise can be attributed to the recent announcement of assay results from the company's Apex project, which have sparked investor interest and optimism about future production.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Blue Moon Zinc Corp
MOON.V
MOON.V
Blue Moon Zinc Corp
Market cap
$749.77M
52W high
$11.80
52W low
$2.96
1W change
-1.07%
Beta
0.88
Analyst Price Targets
Based on analyst covering MOON
Wall Street analysts forecast MOON stock price to rise 107.8% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$15.38
+107.8% Upside
Current Price
C$7.40
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MOON's historical volatility
30-Day Vol
64.1%
Annualized
90-Day Vol
77.9%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$6.19
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$6.97 | C$5.59 – C$8.70 |
| 60 trading days | C$6.57 | C$4.80 – C$8.98 |
| 90 trading days | C$6.19 | C$4.22 – C$9.08 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: The positive assay results from the Apex project highlight Blue Moon's potential in the critical metals market, particularly as demand for germanium and gallium continues to rise.
5.05% Surge in Stock Price
Blue Moon Zinc Corp's stock increased by 5.05% in the last session, reflecting strong market interest following positive assay results.
Bull case
The assay results show significant concentrations of germanium, gallium, and copper. This positions Blue Moon to benefit from the growing global demand for these metals, especially in tech and renewable energy sectors.
Bear case
Even with the good news, investors should stay cautious. The actual mining operations are still in the permitting phase, and market conditions can be unpredictable.
Positive Assay Results Fuel Investor Optimism
Advertisement
Blue Moon recently reported assay results from its Apex project, revealing 0.180% germanium, 0.0273% gallium, and 1.96% copper. These findings are particularly significant as they come at a time when prices for germanium and gallium have been rising, with current spot prices reaching $10,500/kg and $2,650/kg respectively. This positions Blue Moon favorably within the critical metals market, which is seeing increased demand across various industries.
Strategic Moves Ahead
The company is actively working on its metallurgical program to explore commercialization options for the Apex project. With ongoing discussions about contract mining and the potential to supply nearly 100% of U.S. germanium demand, Blue Moon is setting the stage for significant growth. Investors are keenly watching these developments as they could lead to increased revenue streams in the near future.
Market Reaction and Future Outlook
Following the announcement of the assay results, Blue Moon's stock saw a robust increase in trading volume, reflecting strong investor interest. However, potential risks remain, including the need for timely permitting and the overall volatility of the mining sector. As the company progresses towards operational readiness, investors should keep an eye on market conditions and Blue Moon's ability to execute its plans effectively.
Advertisement
Advertisement

Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.


